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2310Objective: Machine perfusion of donor hearts is a promising strategy to increase the donor pool. Antegrade
perfusion is effective but can lead to aortic valve incompetence and nonnutrient flow. Experiencewith retrograde
coronary sinus perfusion of donor hearts has been limited. We tested the hypothesis that retrograde perfusion
could support myocardial metabolism over an extended donor ischemic interval.
Methods: Human hearts from donors that were rejected or not offered for transplantation were preserved for
12 hours in University of Wisconsin Machine Perfusion Solution by: (1) static hypothermic storage;
(2) hypothermic antegrade machine perfusion; or (3) hypothermic retrograde machine perfusion. Myocardial
oxygen consumption (MVO2), and lactate accumulation were measured. Ventricular tissue was collected for
proton and phosphorus 31 magnetic resonance spectroscopy (MRS) to evaluate the metabolic state of the
myocardium. Myocardial water content was determined at the end of the experiment.
Results: Stable perfusion parameters were maintained throughout the perfusion period with both perfusion
techniques. Lactate/alanine ratios were lower in perfused hearts compared with static hearts (P<.001). Lactate
accumulation (antegrade 2.0  0.7 mM, retrograde 1.7  0.1 mM) and MVO2 (antegrade 0.25  0.2 mL,
retrograde 0.26  0.3 mL O2/min/100 g) were similar in machine-perfused groups. High-energy phosphates
were better preserved in both perfused groups (P<.05). Left ventricular myocardial water content was increased
in retrograde perfused hearts (80.2  0.8%) compared with both antegrade perfused hearts (76.6  0.8%,
P ¼ .02) and static storage hearts (76.7  1%, P ¼ .02).
Conclusions: Machine perfusion by either the antegrade or the retrograde technique can support myocardial
metabolism over long intervals. Machine perfusion seems promising for long-term preservation of human donor
hearts. (J Thorac Cardiovasc Surg 2014;148:2310-5)Supplemental material is available online.
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The Journal of Thoracic and Cardiovascular Surdonor organs, and possibly the use of non-heart-beating
donors.1-3 Most studies investigating machine perfusion
for heart transplantation either by warm, beating-heart
perfusion or cold perfusion use antegrade perfusion of the
coronary arteries by delivery of the perfusate into the
ascending aorta.4-6 Research by our laboratory and others
have confirmed that machine perfusion preservation is
more effective than conventional static storage after
standard and long-term ischemic intervals.5-7 However,
we have previously reported that under some conditions,
aortic insufficiency and thus nonnutrient flow could
occur.8 In clinical practice, the likelihood of significant
aortic valve incompetence would be even greater during
the conditions encountered when traveling to procure donor
hearts. This is of minor consequence in the cold perfused
heart over a standard ischemic interval because these hearts
would essentially be undergoing static storage, but may
prove devastating during normothermic perfusion or over
extended donor ischemic intervals.
Retrograde perfusion through the coronary sinus avoids
the possibility of aortic insufficiency and is used routinely
for cardioplegia delivery during cardiac surgery9,10 but its
use for machine perfusion of donor hearts is rudimentarygery c November 2014
Abbreviations and Acronyms
ATP ¼ adenosine triphosphate
ANOVA ¼ analysis of variance
MRS ¼ magnetic resonance spectroscopy
MVO2 ¼ myocardial oxygen consumption
PCr ¼ phosphocreatine
Pi ¼ inorganic phosphate
UWMPS ¼ University of Wisconsin Machine
Perfusion Solution
Cobert et al Evolving Technology/Basic Scienceat best.11 Furthermore, we previously reported that right
ventricular perfusion was reduced in canines when using
retrograde perfusion, illustrating a potential limitation of
this technique.12
The ability of either technique to preserve human
hearts over extended ischemic intervals has not been well
characterized.We therefore decided to investigate themyocar-
dial metabolism of human hearts perfused by either antegrade
or retrograde machine perfusion and compare this with con-
ventional static storage.We hypothesized that machine perfu-
sion ismore effective than standard cold storage for long-term
preservation of human donor hearts for transplantation.E
T
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This study was conducted in accordance with an organ procurement
organization–approved research protocol. Human donor hearts either not
offered for transplantationor rejected for transplantationbyall centers towhich
they were offered and for tissue donation were assigned to 1 of 3 preservation
techniques: (1) cold storage; (2) antegrade machine perfusion; (3) retrograde
machine perfusion. Tissue from additional hearts was procured immediately
after cardiectomy to obtain baseline metabolic parameters.
Perfusion Device
Hearts assigned to the perfusion groups were perfused with a prototype
perfusion device, the LifeCradle (Organ Transport Systems, Inc, Frisco,
Tex). The device delivers temperature-regulated oxygenated perfusate to the
heart. Perfusate temperature, flow, and pressureweremonitored continuously.
Procurement
Organ retrieval was performed through a median sternotomy. The heart
was exposed and the donor was systemically heparinized with 30,000 units
of heparin. After adequate time for heparin circulation had elapsed, the
aorta was crossclamped and 1 L of ice-cold University of Wisconsin
Machine Perfusion Solution (UWMPS) was used to arrest the heart. Hearts
were decompressed through the inferior vena cava and the left atrial
appendage. The donor cardiectomy was completed.
Preservation Techniques
Hearts were preserved for 12 hours by 1 of the 3 techniques.
Conventional hypothermic storage hearts were immersed in 1 L of ice-
cold UWMPS. Hearts in the antegrade perfusion group were perfused
with UWMPS through the ascending aorta at a flow rate of 10 mL/100 g
heart weight/min at 5C  2C. Donor hearts in the retrograde groups
were perfused through a retrograde cardioplegia cannula (Medtronic, Inc,
Minneapolis, Minn) sewn into the coronary sinus with UWMPS at a flowThe Journal of Thoracic and Carrate of 13 to 20 mL/100 g/min, also at 5C  2C. Perfusion group flow
rates were based on previously obtained data on large animals and in
some cases for the retrograde group, maximum achievable flow rate of
the device.8,12 Temperature and perfusion pressure were measured
continuously in machine-perfused hearts. End perfusion myocardial
oxygen consumption (MVO2) and transmyocardial lactate and perfusate
lactate accumulation were determined for most of the perfused hearts
using a commercial analyzer (Radiometer America, Inc, Westlake,
Ohio). Separate MVO2 from right and left coronary artery effluent was
calculated in retrograde perfused hearts. Myocardial water content was
measured from tissue samples at the end of the experiment.
Magnetic Resonance Spectroscopy
The tissue samples were harvested, immediately freeze-clamped, and
cooled in liquid nitrogen. The tissue was stored in a freezer at 80C
and subsequently extracted with perchloric acid. Purified extracts were
reconstituted in deuterium oxide, and the pH was adjusted to 7.0 to 7.4
for magnetic resonance spectroscopy (MRS). Proton (1H) MR spectra
were then acquired with a 14.1-T Varian spectrometer operating at 600
MHz over a spectral width of 8000 Hz. Lactate-to-alanine ratios were
compared from 1H spectra as measures of cellular aerobic and anaerobic
metabolism during storage.13,14 Proton-decoupled phosphorus 31 (31P)
spectra were obtained on the same spectrometer tuned to the 31P nucleus
operating at 243 MHz over a spectral width of 36,000 Hz. Phosphocreatine
(PCr)/inorganic phosphate (Pi), g-adenosine triphosphate (g-ATP)/Pi, and
phosphocreatine/g-ATP ratios were measured to determine the preserva-
tion of high-energy phosphates during the storage interval. Pi, PCr, and
ATP standards were applied to selected samples to verify these signals.
Data Analysis
Data are reported as means  standard error of the mean. Statistical
analysis was performed with SigmaPlot statistical software (SyStat Soft-
ware, Inc, San Jose, Calif) using a 2-sided t test or analysis of variance (AN-
OVA), as appropriate. A log10 function was applied to
31P MRS spectra to
normalize the data. ANOVA on ranks using the Kruskal-Wallis test was
performed on other variables that demonstrated either unequal variances
or a nonnormal distribution. When measurements were collected over mul-
tiple time points, data were compared with repeated-measures ANOVA.
Adjustments for multiple comparisons were performed using the Fisher
least significant difference method or the Dunnmethod, as appropriate. Re-
lationships between variables were investigated with the Pearson correla-
tion coefficient.
RESULTS
Demographics
Twenty-eight donor hearts were studied with the 12-hour
storage protocol: 10 using conventional cold storage, 8
using antegrade perfusion, and 7 using retrograde perfusion.
Three additional hearts were used to determine baseline
metabolic parameters immediately after procurement.
Twenty-one hearts were procured using ground transporta-
tion and 7 hearts were procured by air transport. Donors
were reasonably matched for age, ejection fraction, cause
of death, height, and weight. Donor demographics are
shown in Table 1. Seven of the 31 hearts in this study
were offered for donation but rejected for transplantation.
Perfusion Characteristics
Both perfusion groups cooled rapidly within 1 hour to the
set temperature and maintained a stable temperature overdiovascular Surgery c Volume 148, Number 5 2311
TABLE 1. Donor demographics
Control (n ¼ 3) Static (n ¼ 10) Antegrade perfusion (n ¼ 8) Retrograde perfusion (n ¼ 7)
Age, y 48  10 39  6 51  5 43  6
Sex, male/female 1/2 3/7 3/5 2/5
Height, cm 161  7 174  3 171  3 169  3
Weight, kg 78  6 72  3 76  5 91  12
Cause of death
CVA 2 7 6 3
Trauma 1 2
Anoxia 1 2 1 2
Other 1 (cardiac)
Ejection fraction,% 60  0 (n ¼ 1) 53  9 (n ¼ 6) 43  9 (n ¼ 2) 66  2 (n ¼ 4)
LVH 1 2
CAD 2 2
Continuous data are reported as mean standard error of the mean.CVA, Cerebrovascular accident; LVH, left ventricular hypertrophy;CAD, significant coronary artery disease in
1 or more coronary vessels.
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the 2 perfused groups and did not differ between the
right and left coronary artery distribution within the
retrograde perfusion group. Lactate accumulation in both
perfused groups was also low. Inflow and outflow lactate
concentrations were not different across the right and
left coronary distribution in retrograde perfused hearts
(Table 2, P>.2). Perfusion pressures and coronary vascular
resistance were higher in the retrograde group compared
with the antegrade group at most time points. There seemed
to be a decrease in both perfusion pressure and coronary
vascular resistance in the antegrade group over time
compared with retrograde perfused hearts (P ¼ .04 for
pressure, P ¼ .008 for coronary vascular resistance), but
this differencewas not significant for individual time points.Heart Weight Gain and Myocardial Water Content
Potentially important changes in heart weight were noted
over the storage interval. Retrograde perfused hearts
demonstrated weight gain (17.6%  4.4%) compared
with either antegrade perfused hearts (4.9%  4.8%,
P ¼ .002) or static storage hearts (1.3%  2.1%,
P ¼ .016) (Figure 1 and Table E1). This difference was
primarily caused by left ventricular edema as suggested
by the myocardial water content. Left ventricular myo-
cardial water content was higher in the retrograde perfused
hearts (80.2%  0.8%) compared with both the antegradeTABLE 2. Lactate accumulation andMVO2 after 12 hours of machine
perfusion preservation
Group MVO2 (mL/min/100 g) Lactate (mM)
Antegrade 0.25  0.02 2.0  0.3
Retrograde: right coronary artery 0.28  0.04 1.7  0.03
Retrograde: left coronary artery 0.24  0.02 1.7  0.04
Data are reported as means  standard error of the mean. There were no important
differences in MVO2 or lactate accumulation in the preservation solution between
groups (P>.20). MVO2, Myocardial oxygen consumption.
2312 The Journal of Thoracic and Cardiovascular Surperfused hearts (76.6%  0.8%, P ¼ .02) and the static
storage hearts (76.7%  1%, P ¼ .02). Within the
retrograde group, the left ventricular water content was
also higher compared with the right ventricular water
content (75.7%  2%, P ¼ .066) (Table E2).
Metabolism and Energy State
Lactate/alanine ratios by 1H MRS were lower in all
perfused hearts compared with the static storage group,
indicating ongoing oxidative metabolism and reduced
intracellular lactate accumulation in the perfusion groups
(P< .001). Within perfusion groups, the ratio was lowest
in the retrograde left ventricular samples but this difference
was minor compared with either the retrograde perfusion
right ventricular samples or the antegrade group (P>.20)
(Figure 2 and Table E3).
31P MRS also demonstrated that high-energy phosphate
to inorganic phosphate ratios were better maintained in
the perfusion groups. Both perfusion groups demonstratedFIGURE 1. Heart weight. Heart weight increased in retrograde perfused
hearts over the 12-hour preservation interval compared with all other
groups (*P<.05).
gery c November 2014
FIGURE 2. Lactate/alanine ratio. The lactate/alanine ratio was
increased in static storage hearts compared with all other groups
(*P<.001). LV, Left ventricle; RV, right ventricle.
Cobert et al Evolving Technology/Basic Sciencesubstantially higher PCr/Pi, g-ATP/Pi, and PCr/g-ATP
ratios compared with the static storage group (P< .05).
There were no important differences in the PCr/Pi,
PCr/g-ATP ratios between the 2 perfused groups and
control hearts. The g-ATP/Pi ratio tended to be lower in
control hearts compared with the 2 perfusion groups
(Figure 3). There was a strong inverse relationship between
the lactate/alanine ratio and both the PCr/Pi (r ¼ 0.721,
P<.001) and PCr/g-ATP ratios (r ¼ 0.774, P<.001).
No other parameter had a significant association with these
indices of metabolism.DISCUSSION
Results for heart transplantation are superior to any other
solid-organ transplant and this therapy remains the standardFIGURE 3. Phosphocreatine, adenosine triphosphate (ATP), and inor-
ganic phosphate ratios by 31P MRS. The phosphocreatine (PCr)/inorganic
phosphate (Pi) ratio and the PCr/ATP ratiowere greater in the control group
and both perfusion preservation groups compared with static storage
hearts (*P<.05). Both perfusion preservation groups demonstrated higher
ATP/inorganic phosphate ratios compared with the static storage group
(yP<.05). The difference in the ATP/inorganic phosphate ratio may also
be important between both perfused groups and control hearts (P ¼ .051
vs antegrade, P ¼ .07 vs retrograde). MRS, Magnetic resonance
spectroscopy.
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graft failure, likely caused by poor graft preservation is
the major cause of recipient death within 30 days after
transplantation.15 Also, heart transplantation remains
limited by the number of suitable donors and the number
of transplants performed has not changed significantly in
the last decade. Conventional wisdom suggests that most
suitable donor hearts are recovered and transplanted.
However, although the number of all organ donors has
increased recently, the fraction of cardiac donors has
actually decreased. Only 28% of hearts from all
brain-dead donors are used. The conversion rates of
standard criteria cardiac donors between 18 and 50 years
of age remains at less than 50%16 suggesting many
potentially recoverable organs are not used. Reasons for
this are not entirely clear but likely include lack of a
suitable recipient within a reasonable procurement distance,
particularly for smaller donors and less common blood
types (ABO groups B and AB). These factors, in
combination with concerns regarding the impact of
projected ischemic times, may be important contributors
leading to nonuse of many of these otherwise acceptable
donors.
Machine perfusion preservation is a promising technique
for improving the results of organ transplantation especially
by increasing the acceptable donor ischemic interval.17 Its
benefits have been clinically proven in kidney transplanta-
tion18 and, in principle, the benefits in heart transplantation
should potentially be even greater because of the reduced
ischemic tolerance of donor hearts. Perfusion preservation
also offers the possibility for improved donor-recipient
matching, such as by HLA, or extending the donor
pool for highly sensitized patients by permitting for long-
distance procurements and prospective crossmatches.1
Perfusion preservation may be useful to protect hearts
from older donors, donors with left ventricular hypertrophy
or coronary artery disease, donation after circulatory
death, or donors with preexisting reversible ventricular
dysfunction, that is, organs that are otherwise either not
considered for transplantation or at increased risk for
primary graft failure.1,3
Several studies from our laboratory and others demon-
strate that machine perfusion preservation is a promising
technique for increasing the donor pool and improving the
results of heart transplantation. A warm, beating-heart
machine perfusion preservation technique using the Organ
Care System by Transmedics, Inc (Andover, Mass) is
currently undergoing clinical investigation in the United
States and has obtained CE (Conformite Europeenne)
approval in Europe, suggesting increasing enthusiasm for
this technique.4,17
In the current study, we evaluated metabolic indices of
myocardial preservation in human hearts by 2 techniques
of machine perfusion preservation and compared these 2diovascular Surgery c Volume 148, Number 5 2313
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Smachine perfusion preservation techniques to conventional
hypothermic static storage after a 12-hour storage interval.
Our results suggest that perfused hearts from both
perfusion groups continued to consume oxygen over the
preservation period. Lactate accumulation in the perfusate
was low in both perfused groups. Intracellular lactate/
alanine ratios were also reduced suggesting ongoing
oxidative metabolism in perfused groups. In contrast, this
ratio was essentially reversed in conventional static
storage hearts, consistent with anaerobic metabolism. 31P
MRS demonstrated almost complete disappearance of
phosphocreatine and a corresponding increase in inorganic
phosphate in the static groups suggestive of substantial
depletion of high-energy phosphates. This was illustrated
by the decreased phosphocreatine/Pi, g-ATP/Pi, and
phosphocreatine/g-ATP ratios in the static storage hearts
compared with perfused hearts. These ratios were not
different between perfused hearts and immediately
procured tissue from control hearts indicating that
machine perfusion preservation is effective in maintaining
myocardial high-energy phosphates even over 12 hours of
cold perfusion.
Comparing perfusion groups, no significant differences
in indices of metabolism were noted over the perfusion
interval. Perfusion pressures in the retrograde perfused
hearts were higher, likely as a result of the increased flow
rates used compared with antegrade perfused hearts.
Coronary vascular resistance was also increased but this
difference was not significant for any individual time point.
Heart weight gain in the retrograde group and the
corresponding slight weight loss in the antegrade group
over the perfusion period may explain the difference in
coronary vascular resistance noted between these groups.
Myocardial water content was also increased in retrograde
perfused left ventricular tissue (but not right ventricular
tissue) suggestive of increased myocardial edema during
preservation. Perfusion pressure and coronary vascular
resistance in the retrograde group did not change after the
first hour, indicating that the development of edema was
an early event that did not change over time. The
significance of the increased water content is unclear.
Flow rate–dependent increases in heart weight are well
characterized using these models. At least 2 previously
published reperfusion experiments suggest that this weight
increase is not necessarily associated with worse
reperfusion cardiac function in organs that maintain
satisfactory indices of oxidative metabolism.19,20 This
may be because, as Amirhamzeh and colleagues19 have
suggested, hydrostatic edema resolves when systolic forces
return interstitial fluid to the intravascular space after
reperfusion, as long as endothelial integrity is maintained.
Our own experience in a large-animal model of
machine perfusion preservation over shorter intervals also
demonstrated that, despite significant weight gain during2314 The Journal of Thoracic and Cardiovascular Surthe storage interval, myocardial function after implantation
was not affected and myocardial water content after
reperfusion was not increased.6,8
Both perfusion techniques have potential limitations. For
antegrade perfusion, aortic valve incompetence is a possible
concern based on experimental studies from our laboratory.
Its significance is unclear. Noncoronary flow may result but
aortic insufficiency with a competent mitral valve would
eventually result in perfusion of the coronaries although
this might be at the cost of some left ventricular distention
during storage. As noted, both aortic and mitral valve
incompetence might have devastating consequences over
prolonged ischemic intervals or for recovery of marginal
donors but its impact after a standard storage interval would
likely be minor. In the current study, despite significant
ground and air travel, no convincing evidence of impaired
myocardial perfusion could be detected in any of the
antegrade perfused hearts.
Retrograde perfusion preservation of human hearts has
only rarely been described but this technique is used
commonly for cardioplegia delivery during cardiac surgery.
The major potential concerns with this technique include
less efficient perfusate delivery21 and reduced nutrient
flow to the right ventricle.22 In animal studies from our
laboratory, higher flow rates were required with retrograde
perfusion to achieve adequate myocardial perfusion. In
these same experiments, right ventricular lactate/alanine
ratios were increased and tissue flow was decreased by
microsphere analysis suggesting reduced nutrient delivery
to the right ventricle with this technique.12 The current
study in human hearts, however, did not demonstrate any
impairment in right ventricular perfusion. MVO2 values
calculated from right and left coronary effluent were not
different. Also, lactate/alanine ratios were similar between
retrograde right ventricular, retrograde left ventricular,
and antegrade left ventricular tissue indicating adequate
tissue flow. Arteriovenous PO2 differences in the retrograde
group suggest that in humans, lower flow rates can be used
with this technique, which may reduce and potentially
eliminate any differences in myocardial water content
compared with the antegrade perfusion and static storage
groups. These findings may in part be related to differences
in cardiac venous anatomy between human and canine
hearts as others have suggested.23
This study has several limitations. Donor characteristics
and organ quality (such as donor age, ejection fraction,
donor weight, donor height, or cardiac risk factors) were
variable between and within groups. None of these
factors, however, correlated with lactate/alanine ratios or
high-energy phosphate/Pi ratios. Organs were also not
randomly assigned to groups mainly for logistical reasons.
Perhaps most importantly, although these data indicate
that myocardial metabolism and high-energy phosphate
levels are preserved after long-term cold perfusion ofgery c November 2014
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recovery of these organs. Transplantation of these organs
was not performed for ethical reasons. We are currently
investigating transplantation after long-term machine
perfusion preservation in a large-animal model to evaluate
posttransplant ventricular performance. Despite the noted
limitations, the parameters measured in the current
experiments have been used to predict human cardiac
allograft function after implantation clinically. Increasing
lactate levels during warm, beating-heart perfusion in the
Organ Care System by Transmedics, Inc, are currently
used to reject donor hearts procured for clinical transplanta-
tion.4 In studies by Caus and colleagues,24 reduced PCr/Pi
and ATP/Pi ratios were associated with poor graft outcomes
and ratios similar to our experience were associated
with improved functional recovery and reduced graft
dysfunction after implantation,24 suggesting that transplan-
tation of many of the machine-perfused organs used in this
study would have led to a satisfactory outcome. Other
investigators in cardiac and other solid-organ machine
perfusion preservation transplantation models have
demonstrated that the ability to maintain a stable MVO2
is perhaps the most important indicator of satisfactory graft
preservation.1,25 The fact that even organs with known
coronary disease, left ventricular hypertrophy, or reduced
ejection fraction demonstrated preserved indices of
oxidative metabolism and maintenance of myocardial
energy stores suggests that some of these organs could
potentially be transplanted under the appropriate clinical
conditions.
In summary, hypothermic machine perfusion preserva-
tion by either antegrade or retrograde perfusion can
support myocardial metabolism over long intervals. Grafts
preserved with these techniques continue to consume
oxygen and maintain high-energy phosphate levels. Our
data suggest that with hypothermic machine perfusion
preservation of donor hearts, storage intervals up to 12 hours
can potentially yield acceptable hearts for transplantation.
These findings will need to be validated in a comparable
model of cardiac transplantation before clinical application.
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TABLE E1. Heart weight change after preservation for 12 hours
Group
Starting
heart weight (g)
Heart weight after
preservation
for 12 hours (g)
Weight
gain (%)
Control 355  65 NA NA
Static 328  21 332  22 6.5  2
Antegrade 438  29 412  26 4.8  5
Retrograde 368  41 431  51 17.6  4*
NA, Not applicable. *P<.001 versus Antegrade, P ¼ .005 versus Static.
TABLE E2. Myocardial water content
Group Water content (%)
Static right ventricle 75.1  1
Static left ventricle 76.7  1.4
Retrograde right ventricle 75.7  2
Retrograde left ventricle 80.2  0.7*
Antegrade left ventricle 76.6  0.8
*P<.05 versus all other groups; antegrade right ventricle results not available.
TABLE E3. Lactate/alanine ratios
Group Right ventricle Left ventricle
Control 0.58  0.1 0.80  0.1
Static 4.2  0.5* 4.4  0.7*
Antegrade Not available 1.2  0.4
Retrograde 1.2  0.2 0.62  0.1
*P<.001 versus all other groups.
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